INTRODUCTION
Mycobacterium tuberculosis is the causative agent of human tuberculosis, a worldwide health problem caus- 
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ing approximately 3 million deaths per year (Bloom & Murray, 1992 ; Dye et al., 1999) . During the early stages of infection, a key determinant of virulence is the ability to survive and replicate within the phagosome of host phagocytic cells, primarily the macrophage (Riley, 1996) . The components of the mycobacterial cell envelope are considered prime determinants for intracellular survival and virulence. The cell wall functions as a permeability barrier that shields the organism from C. A. Rivera-Marrero and others environmental stress, protects from the intracellular attack mechanisms of the macrophage and provides resistance to many antibiotics (Brennan & Nikaido, 1995) . Identification of the molecular determinants associated with virulence, and elucidating the mechanisms of phagolysosomal evasion and intracellular survival are currently among the most important aspects of tuberculosis research.
Sulfated glycolipids of the cell wall of M. tuberculosis were implicated several years ago in virulence. Early studies showed that virulent strains could be distinguished cytochemically by their staining with the cationic dye neutral red (Dubois & Middlebrook, 1948) , leading to the discovery of the neutral-red-reactive sulfolipids (SLs) (Middlebrook et al., 1959) . Since then, several studies have established a correlation between the presence of sulfated glycolipids and the degree of virulence of M. tuberculosis strains (Gangadharam et al., 1963 ; Mitchison, 1964 ; Goren et al., 1974 Goren et al., , 1982 . It has also been proposed that sulfated glycolipids may be involved in intracellular survival of virulent M. tuberculosis by their interaction with phagosomes and prevention of lysosomal fusion (Goren et al., 1976 ; Goren, 1977 ; D'Arcy Hart & Young, 1988 ; Fujiwara, 1997) . More recently, it was shown that M. tuberculosis sulfolipid-I (SL-I) blocked the LPS and gamma interferon (INF-γ) activation of human macrophages for enhanced release of superoxide (Pabst et al., 1988 ; Brosna et al., 1991) . In neutrophils however, SL-1 stimulated superoxide production and primed neutrophil responses to several metabolic agonists such as N-formyl methionylleucyl-phenylalanine (FMLP) and phorbolmyristate acetate (PMA) (Zhang et al., 1988 (Zhang et al., , 1991 . Although these studies strongly implicate SLs as potential virulence factors, the role of SLs in virulence, immune modulation and pathogenicity of tuberculosis remains unclear.
The major sulfated glycolipids of M. tuberculosis consist of a family of trehalose-2-sulfate esters with an array of acyl fatty acids (phthioceranate, hydroxyphthioceranate, palmitate, stearate) at various positions of the trehalose molecule (Goren, 1984) . SL-1, the principal sulfatide of M. tuberculosis, has been identified as 2,3,6,6h-tetraacyl-α,αh--trehalose-2h-sulfate (Goren, 1970a, b) . Although the structure of M. tuberculosis trehalose SLs has been well characterized, their biosynthetic pathways, including enzymes such as sulfotransferases (STs) possibly involved in their biosynthesis and regulation, are not known. The identification of genes encoding these enzymes and the generation of allelic knockout mutants is crucial for determining their role in the biology and pathogenesis of tuberculosis.
In this study we demonstrate that gene Rv1373, a putative aryl-ST gene in M. tuberculosis, encodes a novel glycolipid ST with activity towards the eukaryotic glycolipids galactosylceramide and glucosylceramide, and endogenous mycobacterial glycolipids. This is the first report of a mycobacterial glycolipid ST possibly involved in the biosynthesis of the biologically relevant trehalose SLs of the cell wall of M. tuberculosis. (v\v) glycerol. Mycobacteria were grown at 37 mC with slow shaking for 5-14 days. Bacterial cultures of 10 ml at 3i10) bacteria ml − ", were centrifuged at 3000 g for 15 min and wet pellets processed for preparation of cell lysates and glycolipid extracts.
METHODS

Bacterial
Metabolic labelling and glycolipid isolation. Mycobacterium species M. avium smooth opaque and transparent, M. bovis BCG, M. smegmatis mc#155, and M. tuberculosis strains H37Ra, H37Rv and Erdman were grown in 50 ml cultures of 7H9 broth containing 100 µCi $&S (as sulfate ; 3n7 MBq ; 37 TBq mmol − " ; Amersham Pharmacia) for 5-7 days. Cultures were centrifuged at 3000 g for 10 min, the bacterial pellets were washed in PBS, resuspended in 1n0 ml PBS and sonicated extensively (10 times, 20 s pulses). Glycolipids were extracted by a modification of the Folch method (Morrison, 1994) . Two volumes of chloroform\methanol (2 : 1) were added, the samples were sonicated (20 s), centrifuged (9500 g for 1 min), and the upper (aqueous) and lower (organic) phases saved. The upper phase contains gangliosides and neutral lipids with long carbohydrate chains and contaminating protein ; the lower phase contains the neutral glycolipids with short carbohydrate chains, neutral lipids and phospholipids. The lower organic phase, containing insoluble material, was extracted sequentially in chloroform\methanol\water (4 : 8 : 3), chloroform\methanol (1 : 1), chloroform\water (2 : 1) and 100 % ethanol. After extraction, the pellet of insoluble material was discarded and the extracted aqueous and organic phases were combined, dried in vacuo and resuspended in 50-100 µl chloroform\methanol (2 : 1). Glycolipid samples (approx. 10 000 c.p.m.) were separated by TLC on Silica gel 60 plates (EM Science) with chloroform\methanol\water (65 : 25 : 4), allowed to dry and exposed to X-ray film or a scanning phosphorimager. TLC plates were also stained with orcinol ferric chloride spray (Sigma) and heated at 100 mC until the brownish colour bands of glycolipids were revealed.
Gene cloning. The 0n98 kb putative aryl-ST gene homologue Rv1373, in M. tuberculosis cosmid SCY02B12 (accession no. z81011) (Philipp et al., 1996 ; Cole et al., 1998) , was cloned by PCR amplification of M. tuberculosis genomic DNA. A set of forward (5h-CCCCGAATTCGATGAATTCAGAACACCC-GAT-3h) and reverse (5h-CCCCAAGCTTTCAGTTGGCCG-GGTCGTATC-3h) oligonucleotide primers, with EcoRI and HindIII restriction sites (underlined) incorporated at the 5h ends, were utilized for PCR amplification. PCR amplification was done in 50 µl reaction mixtures under the action of Taq and Pwo DNA polymerases and the Expand Long Template PCR System (Roche) EcoRI and HindIII, the gene was subcloned into the EcoRI\ HindIII site of expression vectors pET-23b (Novagen) and pTRcHisC (Invitrogen). The resulting construct STpET contains the full length M. tuberculosis aryl-ST gene with a 6-histidine fusion at the carboxyl terminus, while the STpTRcHis contains a 6-histidine peptide and an enterokinase cleavage sequence at the amino terminal end of the protein.
The M. tuberculosis aryl-ST gene was also subcloned out-offrame (construct OF-STpTRcHis) to generate an inactive histagged protein for control experiments. Sequence analysis of the M. tuberculosis aryl-ST gene plasmid constructs was done in a 373 ABI Sequencer by the Taq dye-deoxy terminator method using the T7 promoter and T7 terminator primers and gene-specific primers based on published genomic DNA sequence. Sequence data were analysed using GenBank and the NCBI  server (Altschul et al., 1990) .
Expression and purification of recombinant gene Rv1373.
Expression of M. tuberculosis gene Rv1373 as a recombinant fusion protein in Escherichia coli was conducted following Novagen protocols. Plasmid constructs STpET, STpTRcHis and OF-STpTRcHis were introduced into the BL21(DE3) host E. coli strain and T7 RNA polymerase gene-specific transcription induced by addition of 0n8 mM IPTG for 3 h at 37 mC. After induction, cell extracts were prepared by lysis under non-denaturing conditions and separated by metal chelation affinity chromatography using His-Trap resin (Amersham Pharmacia). Histidine-bound proteins were eluted stepwise with 60 mM, 300 mM and 500 mM imidazole buffer (all in 20 mM phosphate, 0n5 M NaCl), pH 7n5. The eluted proteins were dialysed against PBS pH 7n2, concentrated in a Centriprep-10 filter (Amicon), and analysed by SDS-PAGE and Coomassie blue staining. Purified recombinant fusion proteins were stored at k70 mC until tested for ST activity.
ST assays. These were conducted with sonicated cell extracts of M. tuberculosis bacilli and with the purified recombinant M. tuberculosis aryl-ST. Assays with M. tuberculosis extracts consisted of 100 µg protein (containing enzyme and acceptor substrate), 1n0 µCi (37 kBq) donor substrate 3h-phosphoadenosine-5h-[$&S]phosphosulfonate, PAP$&S, (NEN Life Science Products ; 96n2 GBq mmol − "), in 100 µl reaction buffer (40 mM MES\NaOH pH 7n0, 0n05 M NaCl, 0n2 % Triton X-100, 5 mM EDTA). Assays with purified recombinant protein from clones STpET (his-tag at C terminus), STpTRcHis (his-tag at N terminus) and OF-STpTRcHis (out-of-frame) contained 100 µg protein and 100 µg acceptor substrates galactosylceramide, glucosylceramide or sulfatide (Sigma). Assays with M. tuberculosis glycolipids as substrate contained 50-100 µg total glycolipid. Reaction mixtures were incubated for 6 h at 37 mC, then 900 µl water was added to stop the reactions and the samples were separated by reverse phase chromatography in a Sep-Pak C : 18 column pre-equilibrated in water. The column was washed with 15i1 ml aliquots of water to remove hydrophilic molecules and eluted with 10i1 ml aliquots of methanol to elute the hydrophobic lipids. The radiolabelled SL products eluted were determined by scintillation counting, and by TLC and autoradiography on Silica gel 60 plates (EM Science) with chloroform\methanol\water (65 : 25 : 4). ST assays were done in duplicate and controls without enzyme or acceptor substrate were included. Ceramide glycanase digestion. The $&S-labelled glycolipid fractions (approx. 10 000-20 000 c.p.m.) obtained by elution of C : 18 columns in methanol were dried in Eppendorf tubes, and resuspended in 35 µl water, 10 µl 250 mM phosphate buffer pH 5n0 and 1 µl (0n24 mU) ceramide glycanase (Sigma). Enzyme digestions were done for 5 h or overnight at 37 mC. After digestion, reaction mixtures were diluted in 1 ml water and separated by reverse phase chromatography. The $&S-labelled digestion products were determined by liquid scintillation counting, and by TLC and autoradiography as described.
RESULTS
Differences in SL content among Mycobacterium species
Studies were first conducted by metabolic radiolabelling to determine potential differences in glycolipid sulfation among non-pathogenic and pathogenic mycobacterial species. Mycobacteria such as M. avium smooth transparent and opaque strains, BCG, and M. smegmatis were grown in the presence of $&S and total lipids isolated by Folch extraction. Analysis by TLC and autoradiography revealed very few sulfated ($&S-labelled) lipids in these species (Fig. 1a) (Fig. 1a) . By contrast, similar analyses with M. tuberculosis attenuated strain H37Ra, and virulent strains H37Rv and Erdman, revealed abundant expression of SLs. As shown in Fig.  1(b) , six SLs (labelled I-VI) are present in the virulent M. tuberculosis strain Erdman. Interestingly, the most abundant and less polar SL (SL-I) is present in virulent strains (H37Rv, Erdman) but is absent in the attenuated strain H37Ra. The mobility of this SL is slightly lower than a non-polar abundant SL seen in M. smegmatis. These results demonstrate that M. tuberculosis strains more abundantly express several SLs than non-pathogenic mycobacterial species.
M. tuberculosis cell lysates contain ST activity
We attempted to assay the putative ST activity in whole lysates of M. tuberculosis using the donor substrate PAP$&S. After 6 h incubation at 37 mC, the potential $&S-labelled SLs were isolated by reverse-phase chromatography. The elution with methanol of $&S-labelled material from the C : 18 column in assays with cell free lysates of H37Ra is shown in Fig. 2(a) . The peaks of unbound (not shown) and bound material obtained from the C : 18 column were then analysed by TLC. The C : 18 unbound material, presumably protein, is highly polar and does not migrate in the TLC (Fig. 2b) The C : 18 bound material, presumably lipid, exhibited four major bands corresponding to SLs I, II, IV and VI, obtained from $&S-metabolic labelling of M. tuberculosis (Fig. 1b) . The most abundant species obtained were SLs III and VI. Interestingly, the relatively non-polar SL-I, present in virulent strains but not in H37Ra (Fig. 1b) , appears to be sulfated in vitro in ST assays with H37Ra extracts. Assays with cell lysates from H37Rv and Erdman showed consistently lower activity levels in comparison to H37Ra (data not shown). These results demonstrate that M. tuberculosis cell lysates contain glycolipid STs that can utilize PAPS as the donor substrate and transfer sulfate to various endogenous lipid acceptor substrates in vitro.
A putative aryl-ST gene homologue in M. tuberculosis
A gapped  search (Altschul et al., 1990) for ST gene sequences in mycobacteria yielded gene Rv1373 in cosmid SCY02B12 (accession no. z81011), a 981 bp putative ST gene in M. tuberculosis with slight similarity to eukaryotic aryl-STs (Philipp et al., 1996 ; Cole et al., 1998) . The amino acid identities between hypothetical protein Rv1373 and a human hydroxysteroid ST (accession no. U92315) are shown in Fig. 3 . In a stretch of 292 residues there is 24 % identity, 39 % positive residues and 19 % gaps. The highly conserved signature sequences of eukaryotic STs, believed to be involved in PAPS binding and transfer of sulfate, are shown in Fig.  3 . A similar degree of sequence identity is seen by  analysis with many eukaryotic STs, among them : a murine hydroxysteroid ST (accession no. AF026072), a guinea pig oestrogen ST (accession no. U09552), a rat aryl-ST (accession no. X52883), a rat tyrosine-ester ST (accession no. U32372), and a human oestrogen ST (accession no. U08098). No sequence identities were observed, however, with any prokaryotic STs. Gene Rv1373 probably encodes a soluble protein since no transmembrane domains or signal peptide sequences are present, based on PredictProtein prediction analyses (http :\\cubic.bioc.columbia.edu) (Rost, 1996) . (Altschul et al., 1990 is 37 kDa, the size for the His-fusion protein expressed by construct STpET is 39 kDa and 42n5 kDa by STpTRcHis. Both recombinant proteins were expressed in E. coli BL21 cells after 3 h induction with 0n8 mM IPTG and isolated by nickel affinity chromatography. As shown in Fig. 4 , induction of STpET transformants results in the expression of a 39 kDa protein. The histagged protein was separated by nickel column chromatography and eluted with 300 mM imidazole (Fig. 4) . Similar results were obtained for the purification of the 42n5 kDa his-tagged protein from STpTRcHis and OFSTpTRcHis transformants (data not shown).
The M. tuberculosis aryl-ST gene encodes a glycolipid ST
The purified 39 kDa and 42n5 kDa fusion proteins were first tested for PAPS ST activity towards known substrates of eukaryotic glycolipid STs such as sulfatide (3h-sulfate galactosylceramide), type I galactosylceramide, type II galactosylceramide and glucosylceramide (cerebroside). Assays contained the recombinant protein, PAP$&S, the glycolipid acceptor, and the reaction products were separated by reverse-phase chromatography. The unbound hydrophilic molecules were eluted in water and the bound hydrophobic lipids eluted in methanol. The radiolabelled SLs eluted were determined by scintillation counting. The recombinant M. tuberculosis Aryl-ST (STpET) shows ST activity towards the eukaryotic glycolipids (Fig. 5a ). The highest peak of labelled product was obtained with glucosylceramide, followed by type I and type II galactosylceramides. The efficiency in the transfer of $&S from PAP$&S to these substrates was 3n5 %, 2n4 % and 1n5 %, respectively. As expected, little activity was obtained with already sulfated galactosylceramide (sulfatide), which showed less than 0n1 % efficacy. without insert and the out-of-frame gene construct OFSTpTRcHis, (data not shown). The products of ST reactions were then analysed by TLC and autoradiography as shown in Fig. 5(b) . The left panel shows orcinol staining of glycolipid substrates GalCer Type I, GalCer Type II and GluCer before incubation with the enzyme. The right panel shows the autoradiogram of the $&S-labelled reaction products (6 000 c.p.m. per sample) after incubation with the recombinant M. tuberculosis aryl-ST. As expected, sulfation of the various glycolipids results in increased polarity and slower migration in the TLC. These data demonstrate that the recombinant M. tuberculosis aryl-ST protein encodes a functional ST capable of acting on several glycolipid acceptors. To confirm that the sulfate residue was added to the saccharide moiety of the glycolipid acceptors, the $&S-labelled glycolipids (10 000-20 000 c.p.m.) were treated with ceramide glycanase and the digestion products separated by reverse-phase chromatography. Treatment of $&S-galactosylceramide products (GalCer Type I and II) with ceramide glycanase resulted in the release of $&S-labelled material (" 20-30 % of total radioactivity) that eluted with the aqueous phase (unbound) instead of the lipid phase (bound) (Fig. 6a) . Analysis of the aqueous (unbound) phase and the lipid (bound) phases by TLC and autoradiography revealed that the ceramidasedigested aqueous material migrated close to the origin as free $&S-galactose, while the lipid phase consisted of undigested $&S-GalCer Type I and II products (Fig. 6b) . A second digestion of the ceramidase-resistant material resulted in the release of more $&S-galactose (20-30 %) in the aqueous phase, suggesting that the ceramide glycanase utilized has relatively low activity toward monosaccharide glycosphingolipids such as galactosyl-and glycosylceramide. Nevertheless, these results demonstrate that the activity of the M. tuberculosis ST is towards the sugar moiety (galactose or glucose) of typical eukaryotic glycolipid substrates.
We then tested the M. tuberculosis ST for activity towards endogenous mycobacterial glycolipids. Assays were performed with total glycolipids from H37Ra bacilli prepared by Folch extraction (50-100 µg) and the purified recombinant M. tuberculosis ST (100 µg). H37Ra glycolipids were used because they are less sulfated than those from H37Rv and Erdman strains (as shown in Fig. 1) . Separation of the reaction products by reverse-phase chromatography yielded a peak of $&S-labelled lipid corresponding to approximately 30 % (20 000 c.p.m.) of the total radioactivity applied. Fig. 7 shows the $&S-labelled reaction products isolated by reverse-phase chromatography and analysed by TLC and autoradiography. As shown, one major band (indicated by an arrow) of $&S-labelled glycolipid was Glycolipid sulfotransferase in M. tuberculosis 
DISCUSSION
Sulfated glycolipids of M. tuberculosis consist of trehalose-2-sulfate esters that are associated with the outermost layer of the cell wall. They are considered among the most characteristic components of virulent mycobacteria (Goren, 1984) . Several studies established a correlation between the presence of neutral-red-reactive SLs and the degree of virulence in guinea pigs (Goren et al., 1974 (Goren et al., , 1982 . We demonstrated by metabolic labelling with $&S that M. tuberculosis strains synthesize abundant SLs (4-6 bands by TLC analysis) in comparison to nonpathogenic mycobacterial species such as M. avium, M. bovis BCG and M. smegmatis. In addition, we found that virulent laboratory strains of M. tuberculosis, H37Rv and Erdman, synthesize an abundant and relatively non-polar SL (shown as SL-I) that is not present in the attenuated strain H37Ra. Although the molecular structure of these SLs is not addressed in the present study, it is presumed that these abundant SLs correspond to those previously characterized as the SL-I-IV series (Goren, 1970a (Goren, , b, 1984 . SL-I, 2,3,6,6h-tetraacyl trehalose-2h-sulfate, has been shown to be the most abundant SL (Goren, 1984) and a good marker to differentiate between M. tuberculosis strains and other mycobacterial species (Luquin et al., 1992) .
Since the structure of M. tuberculosis trehalose SLs is well characterized, but most of their biosynthetic enzymes are not known, we tested for the presence of SL STs in cell free lysates of M. tuberculosis. ST assays utilizing PAP$&S as the donor substrate and cell lysates of H37Ra, containing enzyme and acceptor lipid substrates, showed ST activity towards four endogenous lipids. One of the sulfated products is the abundant and relatively non-polar SL-I present in virulent strains but absent in H37Ra after metabolic labelling. This suggests that sulfation of this particular glycolipid may be regulated in vivo at either the enzyme or the substrate level. We also found that assays with cell lysates of H37Rv and Erdman typically showed lower activity than those with H37Ra. We attributed these differences to the availability of unsulfated glycolipid substrates in the cell lysates of H37Ra in comparison to H37Rv and Erdman. Nevertheless, the fact that soluble ST activity was identified in crude cell lysates prompted us to search for ST gene sequences in M. tuberculosis.
The M. tuberculosis gene Rv1373 showed slight similarity (24 %) to eukaryotic aryl-STs but it contains the highly conserved signature sequences regions I and IV, which are involved in PAPS binding and transfer of sulfate (Weinshilboum et al., 1997) . Gene Rv1373 showed no homology to a Klebsiella aryl-ST (Baek et al., 1996) and is the only sequence in the M. tuberculosis genome with similarity to eukaryotic aryl-STs (Cole et al., 1998) . Other putative ST genes in M. tuberculosis, such as genes Rv2392 (cysH), , and Rv0815c-0814c (cysA2-sseC), show similarity to prokaryotic cysteine thio-STs (Cole et al., 1998) and are possibly involved in the assimilatory pathway of cysteine biosynthesis (unpublished data). Interestingly, a  analysis of Rv1373 against the M. bovis virulent strain AF2122\97 sequence database from the Sanger Centre (www.sanger.ac.uk) showed a gene homologue in Contig 281 with 99 % identity. However, this sequence shows nucleotide changes such as an extra C at position 455 and a C to T change (Pro to Leu) at position 692. The extra nucleotide change would result in a frameshift at amino acid 155, a premature termination after residue 264 and truncation of 31 aa at the carboxyl terminus of the protein. This truncation would possibly result in inactivation of the enzyme since this region contains the highly conserved signature sequence region IV. Since we showed that BCG is almost devoid of sulfated glycolipids, future studies are designed to determine if the lack of SLs is due to a mutated Rv1373 gene homologue.
Gene Rv1373 was cloned by PCR, expressed in E. coli as a recombinant histidine-fusion protein and isolated by affinity chromatography. The purified fusion protein was first tested for PAP$&S ST activity towards known substrates of eukaryotic glycolipid STs. The eukaryotic ceramide glycolipids were used since they are simple glycolipids that are commercially available in sulfated or desulfated form. We demonstrated that the recombinant M. tuberculosis aryl-ST protein was able to transfer sulfate to glucosylceramide and galactosylceramide (Type I and II) but not sulfatide (3h-sulfate GalCer). The inability to sulfate sulfatide suggests that sulfation of galactosylceramide may occur at carbon 3 of the galactose. In addition, treatment of sulfated products with ceramide glycanase showed that sulfation was associated with the sugar moiety (galactose or glucose) of the glycolipid. To further determine the function of the recombinant M. tuberculosis aryl-ST, assays were performed with total glycolipids extracted from H37Ra bacilli. The M. tuberculosis aryl-ST was capable of efficiently transferring sulfate to several glycolipids in a crude mixture. Comparison of the mobility of sulfated products in the TLC to that of typical SLs in H37Rv, obtained after metabolic labelling with $&S, showed that the main product corresponds to SL-IV, while the minor bands correspond to SLs III, V and VI. Interestingly, the most abundant SL (SL-I) was not produced. We showed that SL-I is not found in H37Ra after metabolic labelling ( Fig. 1) , but can be produced in PAPS assays with cell free lysates of H37Ra (Fig. 2) . This suggests that synthesis of SL-I requires other STs or factors only present in the cell lysates. Also, it is possible that the acceptor substrate required for SL-I synthesis is present in limited quantities in H37Ra in comparison to the virulent strains H37Rv and Erdman. Taken together, these studies show that gene Rv1373 encodes a novel glycolipid ST in M. tuberculosis with broad specificity and that could be involved in the biosynthesis of trehalose SLs in M. tuberculosis.
In mammals, cytosolic aryl-STs, such as the hydroxysteroid, phenol, monoamine and oestrogen-sulfating types, function in the detoxification of xenobiotic molecules and the metabolism of steroids and bile acids (Falany, 1997) . The other class of STs are membranebound Golgi STs that are responsible for sulfation of glycosaminoglycans (GAGs), glycoproteins and glycolipids (Falany, 1997) . The M. tuberculosis ST is a novel enzyme since it is cytosolic, shows similarity to eukaryotic cytosolic aryl-STs but not to glycolipid STs and is active towards cerebroside glycolipids. There are few examples of prokaryotic glycolipid STs. The soil proteobacterium Rhizobium sp. secretes specific lipo-chitooligosaccharide signals called Nod factors that are required for infection and nodulation of legumes (Varin et al., 1997) . Sulfation of these glycolipids is catalysed by STs encoded by the nodH (Bourdineaud et al., 1995 ; Ehrhardt et al., 1995 ; Schultze et al., 1995) and noeE (Hanin et al., 1997) genes, which are also required for host specificity and biological activity. The NodH ST has specificity toward terminal N-acetylglucosamine residues of lipochitooligosaccharides (Roche et al., 1991) , while the NodE ST is fucose specific (Hanin et al., 1997 ; Quesada-Vincens et al., 1998) . In M. tuberculosis, sulfation of cell wall glycolipids has been implicated in evasion of bacilli from the phagolysosomal compartment of the macrophage (Goren, 1977 ; Goren et al., 1982 Goren et al., , 1987 . However, because of the lack of knowledge about the genes and biosynthetic pathways involved, their function in virulence and pathogenicity has not been defined. Recently, a gene locus encoding polyketide synthase genes (pks2) was shown to encode the synthase for hepta-and octamethyl-branched fatty acids in SLs. A gene knockout of pks2 resulted in mutants of H37Rv lacking SLs (Sirakova et al., 2001) . This finding, and the present work showing the first glycolipid ST in M. tuberculosis are important steps towards defining the biological role of SLs. Other aspects of their biosynthesis such as the synthesis of trehalose, the synthesis of sulfate donor substrates (PAPS), the transfer of fatty acids to trehalose, and their translocation and assembly into the Glycolipid sulfotransferase in M. tuberculosis cell wall, are equally important. Further studies are under way to fully characterize the M. tuberculosis glycolipid ST, determine the molecular structure of its endogenous substrates, generate gene knockout mutants, and define its role in the biology of M. tuberculosis.
